Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
Clinical Neuroradiology|March 9, 2016
Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR ImagingJ Cha, S T Kim, D-H Nam, et al.
British Journal of Cancer|April 13, 2013
Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancerJ C Kim, Y J Ha, S A Roh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2021
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapyR Kim, M Kwon, M An, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 6, 2022
A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal CancerH Jo, M-S Lee, Y-P Lee, et al.
Oncogene|May 24, 2017
LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesisJ-Y Lee, J-H Park, H-J Choi, et al.
Oncoimmunology|February 8, 2019
PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancerH K Angell, J Lee, K-M Kim, et al.
British Journal of Cancer|June 27, 2007
A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future managementH-S Lee, S T Kim, J Lee, et al.
Endoscopy|November 3, 2004
Accuracy of magnetic resonance cholangiopancreatography for locating hepatolithiasis and detecting accompanying biliary stricturesD H Park, M H Kim, S S Lee, et al.
British Journal of Cancer|May 5, 2005
Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancerS T Kim, W K Kang, J H Kang, et al.
Molecules and Cells|March 24, 1998
Insulin has a limited effect on the cell cycle progression in 3T3 L1 fibroblastsL Y Khil, J Y Kim, J B Yoon, et al.
Pageof 23